Reform Multiple Sclerosis MS Disease Modifying Therapy prescription drug costs which have risen 700% in 20 years.

The costs of Multiple Sclerosis MS disease modifying therapies have increased at over 700% in the last 20 years. The cost should go down over time, not increase 700%. None of these drugs costs less than $50,000 per year. Medicare pays 40% of over $6,000 for a month's supply of a DMT drug. That leaves $2000 per month for patients to pay which is more than most people on disability make in a month. So there are charities the drug companies contribute to that pay for the remaining $2000. The drug companies still collect a whopping $4000 a month from Medicare. We need to change our current free-market drug pricing system and rein in the exorbitant pricing for drugs which is burdening our health care system.